Portrait of Professor Rigmor Jensen

Migraine - Management


Perspectives on strategically managing medication-overuse headache

Medication-overuse headache (MOH) is present in about 2% of the global general population, and results in major disability worldwide. Prof. Rigmor Jensen shares insights into the diagnosis and treatment of MOH at the Danish Headache Center, and highlights the importance of patient education and the impact of COVID-19 on her patients with migraine.

Login to register to read this article

If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.

Log In

Not registered yet? Register now